相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevalence of symptoms associated with polycystic ovary syndrome
Asa Lindholm et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2008)
Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity
R. Slopien et al.
GYNECOLOGICAL ENDOCRINOLOGY (2006)
Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome
JC Lo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives
AJ Cussons et al.
ATHEROSCLEROSIS (2006)
Endothelial dysfunction in PCOS: Role of obesity and adipose hormones
E Carmina et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome
A Vryonidou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Tissue plasminogen activator antigen is strongly associated with myocardial infarction in young women
PM Mannucci et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome
F Carmassi et al.
THROMBOSIS RESEARCH (2005)
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome
F Orio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome
EO Talbott et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?
F Orio et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2004)
The prevalence and features of the polycystic ovary syndrome in an unselected population
R Azziz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels
E Diamanti-Kandarakis et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
The plasminogen activator system in young and lean women with polycystic ovary syndrome
I Tarkun et al.
ENDOCRINE JOURNAL (2004)
Impaired carotid viscoelastic properties in women with polycystic ovaries
K Lakhani et al.
CIRCULATION (2002)
Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome
H Yarali et al.
FERTILITY AND STERILITY (2001)
Internal carotid-artery response to 5% carbon dioxide in women with polycystic ovaries
K Lakhani et al.
LANCET (2000)
Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study
S Wild et al.
CLINICAL ENDOCRINOLOGY (2000)
Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS)
WU Atiomo et al.
CLINICAL ENDOCRINOLOGY (2000)
分享论文
